Glaucoma is the most common ocular disease in Parkinson's

Article

The most frequent ocular complaints in patients suffering from Parkinson's disease (PD) are dry eye syndrome and glaucoma.

According to research published in Klinica Oczna the most frequent ocular complaints in patients suffering from Parkinson's disease (PD) are dry eye syndrome and glaucoma.

The results, compiled by Dr Nowacka et al., Department of Ophthalmology, Pomeranian Medical Academy, Szczecin, Poland, were based on information published in the PubMed library.

Diagnosis of ocular diseases, symptoms and bioelectrical dysfunction of the PD patients was performed using tear film tests, perimetry, optical coherence tomography (OCT) and colour and contrast sensitivity tests, as well as electrophysical recordings such as EOGs, flash pattern and multifocal ERGs and VEPs.

The most frequent ocular diseases within PD patients were determined to be dry eye and glaucoma. Additionally, the most prominent bioelectrical dysfunction was identified in the outer layers of the retina and was found in EOG, PERG and mfERG tests.

As a result, it was found that PD visual deficits could occur without any significant changes in routine examination. Extra attention should be given to the diagnosis and treatment of both glaucoma and dye eye syndrome during the examination of patients with PD.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.